Technology
Health
Pharmaceutical

PhaseBio

$10.18
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.15 (1.50%) As of 10:12 AM EDT today
+$0.15 (1.50%) Today

Why Robinhood?

You can buy or sell PhaseBio and other stocks, options, ETFs, and crypto commission-free!

About PHAS

PhaseBio Pharmaceuticals, Inc. Common Stock, also called PhaseBio, is engaged in the development and commercialization of biotherapeutics for the treatment of orphan diseases. Read More It focuses on cardiopulmonary disorders. The company was founded by Ashutosh Chilkoti and Clay Bernardin Thorp in January 2002 and is headquartered in Malvern, PA.

Employees
24
Headquarters
Malvern, Pennsylvania
Founded
2002
Market Cap
245.72M
Price-Earnings Ratio
Dividend Yield
Average Volume
112.67K
High Today
$10.23
Low Today
$9.95
Open Price
$10.00
Volume
34.43K
52 Week High
$16.65
52 Week Low
$2.55

Collections

Technology
Health
Pharmaceutical
2018 IPO
US
North America

PHAS Earnings

-$10.45
-$7.05
-$3.66
-$0.26
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
Actual
Expected Aug 8, After Hours
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.